MC2041A1 - Agents anti-atherogenic - Google Patents

Agents anti-atherogenic

Info

Publication number: MC2041A1
Authority: MC; Monaco
Prior art keywords: atherogenic agents; atherogenic; agents
Prior art date: 1988-06-24

Application number

MC892061A

Other languages

English (en)

Inventor

Johannes Cornelius Str Andries

Original Assignee

Johannes Cornelius Str Andries

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-06-24

Filing date

1989-06-20

Publication date

1990-05-30

1989-06-20 Application filed by Johannes Cornelius Str Andries filed Critical Johannes Cornelius Str Andries

1990-05-30 Publication of MC2041A1 publication Critical patent/MC2041A1/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/105—Persulfides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Inorganic Chemistry (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MC892061A 1988-06-24 1989-06-20 Agents anti-atherogenic MC2041A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ZA884556		1988-06-24

Publications (1)

Publication Number	Publication Date
MC2041A1 true MC2041A1 (fr)	1990-05-30

Family

ID=25579302

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MC892061A MC2041A1 (fr)	1988-06-24	1989-06-20	Agents anti-atherogenic

Country Status (8)

Country	Link
EP (1)	EP0347864A3 (fr)
JP (1)	JPH0267216A (fr)
AU (2)	AU3673789A (fr)
DK (1)	DK313989A (fr)
IL (1)	IL90732A0 (fr)
MC (1)	MC2041A1 (fr)
NO (1)	NO892617L (fr)
NZ (1)	NZ229670A (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1995015750A1 (fr) *	1993-12-10	1995-06-15	Hashim Sami A	Reduction de la probabilite d'apparition de troubles vasculaires chez des sujets a risque
DE69501421T2 (de) *	1994-04-28	1998-04-23	Eisai Co Ltd	Hematetrenome Derivat als antiarteriosklerotisches Mittel
AU5259296A (en) *	1995-04-07	1996-10-23	Warner-Lambert Company	Flavones and coumarins as agents for the treatment of athero sclerosis
DE19538666A1 (de) *	1995-10-17	1997-04-24	Leniger Follert Elfriede Prof	Arzneimittel zur Behandlung von arteriellen Verschlußkrankheiten, Mikroangiopathien und Mikrozirkulationsstörungen
US6025369A (en) *	1996-05-03	2000-02-15	The Board Of Regents Of The University Nebraska	N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis
KR100213895B1 (ko) *	1996-10-14	1999-08-02	박원훈	감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
US6262111B1 (en)	1997-05-21	2001-07-17	Sloan-Kettering Institute For Cancer Research	Method for increasing the concentration of ascorbic acid in brain tissues of a subject
WO1998052560A1 (fr)	1997-05-21	1998-11-26	Sloan-Kettering Institute For Cancer Research	Procede permettant d'augmenter la concentration d'acide ascorbique dans les tissus cerebraux d'un individu
CN1124133C (zh) *	1997-10-28	2003-10-15	韩国科学技术研究院	橙皮苷和橙皮素作为肝病的预防或治疗剂的应用
ES2255309T3 (es) *	1998-10-30	2006-06-16	Merck Patent Gmbh	Compuestos para el tratamiento y la prevencion de enfermedades cardiovasculares.
ES2194513T3 (es) *	1998-10-30	2003-11-16	Merck Patent Gmbh	Composiciones para el tratamiento y prevencion de enfermedades neurologicas y patopsicologicas.
US7608640B2 (en)	1999-03-02	2009-10-27	Jallal Messadek	Glycine betaine and its use
BE1012495A3 (fr) *	1999-03-02	2000-11-07	Messadek Jallal	La glycine-betaine pour son usage antithrombotique.
JP2003503038A (ja) *	1999-06-29	2003-01-28	ザ・ニュージーランド・ミルク・インスティチュート・リミテッド	乳を主成分とする予防的補助食品
BE1015608A6 (fr)	2003-07-15	2005-06-07	Messadek Jallal	Traitement des arterites.
WO2006050581A2 (fr)	2004-11-10	2006-05-18	Jallal Messadek	Betaine en tant qu'agent de lutte contre des maladies transmises par des arthropodes ou des moustiques
EP2242489A1 (fr)	2005-02-15	2010-10-27	Jallal Messadek	Compositions therapeutiques combinees et leurs procedes d utilisation
JP5080011B2 (ja) *	2005-02-28	2012-11-21	第一三共ヘルスケア株式会社	グルタチオンペルオキシダーゼ活性を増加させるための組成物
BRPI0610249A2 (pt)	2005-04-27	2010-06-08	Jallal Messadek	associação ou combinação farmacêutica, composição farmacêutica, processo de co-cristalização e o uso de insulina ou análogo de insulina
CA3145041A1 (fr) *	2019-07-29	2021-02-04	Matthias Rath	Ascorbate dans la prevention de la calcification vasculaire induite par la statine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57197284A (en) *	1981-05-29	1982-12-03	Eiichi Suenaga	Alpha-tocopheryl nicotinate metal complex, its preparation, and remedy for arteriosclerosis comprising it as active ingredient

1989
- 1989-06-20 MC MC892061A patent/MC2041A1/fr unknown
- 1989-06-20 EP EP19890111246 patent/EP0347864A3/fr not_active Withdrawn
- 1989-06-22 NZ NZ229670A patent/NZ229670A/en unknown
- 1989-06-22 AU AU36737/89A patent/AU3673789A/en not_active Abandoned
- 1989-06-23 NO NO89892617A patent/NO892617L/no unknown
- 1989-06-23 IL IL90732A patent/IL90732A0/xx unknown
- 1989-06-23 DK DK313989A patent/DK313989A/da not_active Application Discontinuation
- 1989-06-26 JP JP1160968A patent/JPH0267216A/ja active Pending
1992
- 1992-12-08 AU AU29991/92A patent/AU2999192A/en not_active Abandoned

Also Published As

Publication number	Publication date
JPH0267216A (ja)	1990-03-07
NO892617D0 (no)	1989-06-23
DK313989D0 (da)	1989-06-23
AU3673789A (en)	1990-01-04
NO892617L (no)	1989-12-27
EP0347864A2 (fr)	1989-12-27
NZ229670A (en)	1992-07-28
IL90732A0 (en)	1990-01-18
EP0347864A3 (fr)	1992-04-01
AU2999192A (en)	1993-02-04
DK313989A (da)	1989-12-25

Publication	Publication Date	Title
DE68928739D1 (de)	1998-08-20	Detecteur d'humidite
ATA901789A (de)	1997-07-15	Somatostatinpeptid
BR8806093A (pt)	1990-06-26	Trepano
ATA900689A (de)	1997-01-15	Calcitoninpeptide
ATA172889A (de)	1994-02-15	Furanderivate
MC2041A1 (fr)	1990-05-30	Agents anti-atherogenic
DE68926597D1 (de)	1996-07-11	Mikrorechner
FI91488B (fi)	1994-03-31	Seula
BR8902098A (pt)	1989-12-05	Eletrolisador
DK219589A (da)	1989-11-04	Klaebemiddel
DK113291D0 (da)	1991-06-13	Homogent enzymimmunassay
DK137889A (da)	1989-09-25	Foldeaeske
BR8906898A (pt)	1990-09-25	Jamela
DK182290A (da)	1990-07-31	Foldeaeske
DK165575C (da)	1993-05-10	Loeftesele
DE68926367D1 (de)	1996-06-05	Hydroxymethylcyclobutylpurine
DD277186A3 (de)	1990-03-28	Waelzlagerseparator
IT8807006A0 (it)	1988-10-17	Vespasiano 001
IT8819446V0 (it)	1988-10-27	Legapiu'
SE8800664D0 (sv)	1988-02-26	Sikt
IS3338A7 (is)	1988-11-28	Torleiði-seinkunarlína
BR6801307U (pt)	1989-09-12	Boneco-luva
BR6800589U (pt)	1989-10-31	Capineira
BR8803641A (pt)	1990-03-06	Tele-loto
BR6800002U (pt)	1989-08-22	Multigabarito

Legal Events

Date	Code	Title	Description
1991-06-14	YP	Annual fee paid